The Effects of ?-9-THC and Naloxone in Humans
Conditions
Healthy
What is the purpose of this trial?
The purpose of this project is to examine the effects of mu-opiate antagonism on the rewarding and reinforcing effects of delta-9-tetrahydrocannabinol (THC), the main psychoactive ingredient of cannabis.
Participation Guidelines
- Age:
- 18 Years - 55 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Yale University
- Dates:
- July 2011
- Last Updated:
- March 11, 2013
- Study HIC#:
- 1108008940
Clinicaltrials.gov ID: NCT01591629
For more information about this trial, contact:
Ashley Schnakenberg
203-932-5711 ext 4485
ashley.schnakenberg@yale.edu
Investigator
Deepak D'Souza, MBBS, MD
Principal Investigator
